Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 17, 2005Journal of Clinical OncologyOpen Access

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies

View Full Paper
Ask AI
Bookmark
Share

Authors

UBUdai BanerjiRoyal Marsden NHS Foundation TrustAOAnne O’DonnellGeorgetown UniversityMSMichelle ScurrMurdoch Children's Research Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Banerji et al. (2005) studied this question.

synapsesocial.com/papers/6a5d81c0fbfab74aebc283eehttps://doi.org/10.1200/jco.2005.00.612
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp902001 · 353 citations
  2. 2Structure and Functional Relationships of Hsp902003 · 264 citations
  3. 3Progesterone Receptor Structure and Function Altered by Geldanamycin, an hsp90-Binding Agent1995 · 291 citations
  4. 4Modulation of Akt kinase activity by binding to Hsp902000 · 968 citations